title: [Efficacy of setegis administration after transvesical adenomectomy].
abstract: We studied efficacy ofsetegis in different doses for therapy of lower urinary tract symptoms in patients after transvesical adenomectomy (TVAE). The analysis of case histories of 41 patients after open TVPE for prostatic adenoma has shown that setegis (terazosin) is effective in therapy of urinary bladder overactivity which is present in the majority of patients after TVAE. Compared to the controls, terazosin-treated patients improved urination more noticeably. Thus, alpha-adrenoblocker segetis is effective and safe in therapy of imperative voiding disorders with symptoms of urgent incontinence in patients after TVAE. Use of this drug can significantly contribute to successful postoperative rehabilitation of postadenomectomy patients. Setegis can be recommended for wide clinical practice.
authors.forename: L M
authors.initials: LM
authors.lastname: Gorilovskiĭ
authors.forename: M B
authors.initials: MB
authors.lastname: Zingerenko
authors.forename: D A
authors.initials: DA
authors.lastname: Lakhno
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000534:rehabilitation / Q000601:surgery*; D014554:Urination / Q000187:drug effects*; D014555:Urination Disorders / Q000188:drug therapy* / Q000209:etiology; D013521:Urologic Surgical Procedures, Male
chemical_list: D000317:Adrenergic alpha-Antagonists; C041226:Terazosin; D011224:Prazosin